A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

Cancer

Volumn 116, Issue 2, 2010, Pages 323-330

  Donnelly, Bryan J ^a   Saliken, John C ^b   Brasher, Penelope M A ^c   Ernst, Scott D ^d   Rewcastle, John C ^e   Lau, Harold ^a   Robinson, John ^a,e   Trpkov, Kiril ^e  

^a TOM BAKER CANCER CENTRE   (Canada)

^b Nanaimo Regional Hospital   (Canada)

^c Centre for Clinical Epidemiology and Evaluation   (Canada)

^d LONDON REGIONAL CANCER PROGRAM   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinically localized; Cryoablation; Prostate cancer; Radiation; Randomized trial

Indexed keywords

GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIANDROGEN THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOABLATION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE RETENTION; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; CRYOSURGERY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 75649127997     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24779     Document Type: Article

References (26)

1. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006;175:1326-1331.
2. Koch MO, Gardner TA. Thermal-based treatment options for localized prostate cancer. Curr Treat Options Oncol. 2005;6:379-387.
3. Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int. 2006;97:56-61.
4. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003;17:673-677.
5. Moore CM, Hoh IM, Bown SG, Emberton M. Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer? BJU Int. 2005;96:754-758.
6. Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol. 2004;11: 2110-2117.
7. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001;57:518-523.
8. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 suppl 1):3-11.
9. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: 5-year results. Urology. 2002;60:645-649.
10. Zelefsky MJ, Moughan J, Owen J, Zietman AL, Roach M, 3rd, Hanks GE. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care Survey for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2004;59:1053-1061.
11. Donnelly BJ, Saliken JC. Salvage cryosurgery - how I do it. Rev Urol. 2002;4(suppl 2):S24-S29.
12. Roach M, 3rd, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J RadiatOncol Biol Phys. 2006;65:965-974.
13. Efron B. Forcing a sequential experiment to be balanced. Biometrika. 1971;58:403-417.
14. Makuch R, Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep. 1978;62:1037-1040.
15. Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys. 2000;48:355-367.
16. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16: 1140-1154.
17. Robinson JW, Donnely BJ, Siever JE, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2009;115: 4695-4704.
18. Chin JL, Ng C-K, Touma NJ, et al. Randomized trial comparing cryoablation and external radiotherapy for T2C-T3B prostate cancer. Prostate Cancer. 2008;11:40-45.
19. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977-1984.
20. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169:517-523.
21. Ciezki JP, Klein EA, Angermeier K, et al. A retrospective comparison of androgen deprivation (AD) versus no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004;60:1347-1350.
22. American Society for Therapeutic Radiation and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
23. Lawton CA, DeSilvio M, Roach M, 3rd, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys. 2007;69:646-655.
24. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002;54:677-685.
25. Wilt TJ, Brawer MK. Early intervention or expectant management for prostate cancer. The Prostate Cancer Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer. Semin Urol. 1995;13:130-136.
26. Gardner MJ, Atlman DG, eds. Statistics with Confidence. London, United Kingdom: BMJ Publishing; 1989.